Your browser doesn't support javascript.
loading
Fatal pneumonitis induced by oxaliplatin
Arévalo Lobera, S; Sagastibeltza Mariñelarena, N; Elejoste Echeberría, I; Melé Olivé, M; Egaña Otaño, L; Basterretxea Badiola, L; La Casta Muñoa, A; Azkue Gabilondo, M.
Affiliation
  • Arévalo Lobera, S; Hospital Donostia. Donostia. Spain
  • Sagastibeltza Mariñelarena, N; Hospital Donostia. Donostia. Spain
  • Elejoste Echeberría, I; Hospital Donostia. Donostia. Spain
  • Melé Olivé, M; Hospital Donostia. Donostia. Spain
  • Egaña Otaño, L; Hospital Donostia. Donostia. Spain
  • Basterretxea Badiola, L; Hospital Donostia. Donostia. Spain
  • La Casta Muñoa, A; Hospital Donostia. Donostia. Spain
  • Azkue Gabilondo, M; Hospital Donostia. Donostia. Spain
Clin. transl. oncol. (Print) ; 10(11): 764-767, nov. 2008. ilus
Article in En | IBECS | ID: ibc-123553
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Oxaliplatin has been approved for adjuvant treatment of colorectal cancer. Toxicity induced by oxaliplatin is moderate and manageable, but some isolated cases of severe pulmonary toxicity associated to oxaliplatin have been reported. Two fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis are reported here (AU)
RESUMEN
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: 06-national / ES Database: IBECS Main subject: Organoplatinum Compounds / Pulmonary Fibrosis / Lung Diseases, Interstitial / Antineoplastic Agents, Alkylating / Lung Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Clin. transl. oncol. (Print) Year: 2008 Document type: Article
Search on Google
Add to My VHL
Print
XML
Collection: 06-national / ES Database: IBECS Main subject: Organoplatinum Compounds / Pulmonary Fibrosis / Lung Diseases, Interstitial / Antineoplastic Agents, Alkylating / Lung Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Clin. transl. oncol. (Print) Year: 2008 Document type: Article